# FDA Inspection 1054414 - Coqui Blood Salvage, Inc - May 04, 2018

Source: https://www.keypedia.com/records/fda_inspections/coqui-blood-salvage-inc/43f0410c-bcd6-4bfd-a16d-783edfa4c52b
Source feed: FDA_Inspections

> FDA Inspection 1054414 for Coqui Blood Salvage, Inc on May 04, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1054414
- Company Name: Coqui Blood Salvage, Inc
- Inspection Date: 2018-05-04
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1156494 - 2021-11-05](https://www.keypedia.com/records/fda_inspections/coqui-blood-salvage-inc/5b1154a6-1d84-45cd-95d4-80fbbda8c7fa)
- [FDA Inspection 1156494 - 2021-11-05](https://www.keypedia.com/records/fda_inspections/coqui-blood-salvage-inc/3e9ade95-6051-42a3-af35-fd7ce06e28cf)
- [FDA Inspection 945092 - 2015-10-05](https://www.keypedia.com/records/fda_inspections/coqui-blood-salvage-inc/93b946b5-2d59-4552-9550-874d8e058d57)

Company: https://www.keypedia.com/companies/coqui-blood-salvage-inc/11514228-1f49-4a53-9e64-96f3b78470fc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d